Filing Details

Accession Number:
0000950170-23-026422
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-05 17:03:24
Reporting Period:
2023-06-01
Accepted Time:
2023-06-05 17:03:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB Pharmaceutical Preparations (2834) 831114349
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914164 Iii Morrow Edward Atkinson C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-01 6,250 $2.61 6,250 No 4 M Direct
Common Stock Disposition 2023-06-01 6,250 $17.91 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-06-01 6,250 $0.00 6,250 $2.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2032-05-25 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2023 in multiple trades at prices ranging from $17.53 to $18.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This option represents a right to purchase a total of 6,250 shares of the Issuer's Common Stock, which vested in full on May 16, 2023.